NVO logo

Novo Nordisk A/S (NVO) Return On Equity

Annual ROE

81.76%
-5.53%-6.34%

December 31, 2024

Summary

Performance

1-Year Change

-6.34%

3-Year Change

+14.24%

5-Year Change

+16.02%

15-Year Change

+1.88%

NVO ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

89.41%
NVO annual return on equity is higher than 89.41% of companies in Healthcare sector

High & Low

All-time High

87.29%
NVO annual return on equity is currently -6.34% below its historical high of 87.29%

3-Year Low

69.09%
NVO annual return on equity is currently +18.34% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
NVO previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
NVO next annual earnings announcement has not yet been scheduled

OtherNVOprofitabilitymetrics:

Annual Revenue

$42.13 B
NVO annual revenue is $42.13 billion

Annual Net Income

$14.65 B
NVO annual net profit is $14.65 billion

Annual EPS

$3.28
NVO annual earnings per share is $3.28

Annual ROA

26.24%
NVO annual return on assets is 26.24%

Quarterly ROE

86.85%
-2.10%-2.36%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

-3.27%

3-Year Change

+17.05%

5-Year Change

+17.51%

NVO Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

91.09%
NVO quarterly return on equity is higher than 91.09% of companies in Healthcare sector

High & Low

All-time High

95.26%
NVO quarterly return on equity is currently -8.83% below its historical high of 95.26%

3-Year Low

73.51%
NVO quarterly return on equity is currently +18.15% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
NVO previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

N/A
NVO next earnings announcement has not yet been scheduled

OtherNVOprofitabilitymetrics:

Quarterly Revenue

$12.24 B
NVO quarterly revenue is $12.24 billion

Quarterly Net Income

$4.03 B
NVO quarterly net profit is $4.03 billion

Quarterly EPS

$0.91
NVO quarterly earnings per share is $0.91

Quarterly ROA

27.39%
NVO quarterly return on assets is 27.39%

ROE Formula

ROE =  Net Income
Shareholders Equity ✕ 100%

Annual ROE

81.76%
NVO annual return on equity is 81.76%

Annual Net Income

$14.65 B
NVO annual net profit is $14.65 billion

Annual Shareholders Equity

$20.02 B
NVO annual stockholders equity is $20.02 billion

NVO ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-6.3%-3.3%
3 y3 years+14.2%+17.1%
5 y5 years+16.0%+17.5%

NVO ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-6.3%+18.3%-8.8%+18.1%
5 y5-year-6.3%+20.9%-8.8%+23.0%
alltimeall time-6.3%+714.3%-8.8%+851.3%

Novo Nordisk A/S ROE History

DateAnnualQuarterly
Dec 2024
81.76%(-6.3%)
86.85%(-2.4%)
Sep 2024
-
88.95%(-0.9%)
Jun 2024
-
89.79%(-5.7%)
Mar 2024
-
95.26%(+3.3%)
Dec 2023
87.29%(+26.3%)
92.18%(+2.3%)
Sep 2023
-
90.08%(+8.9%)
Jun 2023
-
82.75%(+4.7%)
Mar 2023
-
79.06%(+7.2%)
Dec 2022
69.09%(-3.5%)
73.73%(-0.8%)
Sep 2022
-
74.29%(+1.1%)
Jun 2022
-
73.51%(-3.1%)
Mar 2022
-
75.86%(+2.2%)
Dec 2021
71.57%(+5.9%)
74.20%(-0.3%)
Sep 2021
-
74.42%(+1.6%)
Jun 2021
-
73.22%(+0.5%)
Mar 2021
-
72.83%(+3.2%)
Dec 2020
67.60%(-4.1%)
70.59%(-2.9%)
Sep 2020
-
72.71%(-1.5%)
Jun 2020
-
73.80%(-2.7%)
Mar 2020
-
75.84%(+2.6%)
Dec 2019
70.47%(-8.1%)
73.91%(-3.3%)
Sep 2019
-
76.40%(+1.5%)
Jun 2019
-
75.26%(-5.5%)
Mar 2019
-
79.68%(-0.6%)
Dec 2018
76.64%(-4.5%)
80.17%(-1.5%)
Sep 2018
-
81.35%(-2.0%)
Jun 2018
-
83.00%(-1.9%)
Mar 2018
-
84.62%(+2.9%)
Dec 2017
80.25%(-5.2%)
82.20%(-4.4%)
Sep 2017
-
85.99%(-1.9%)
Jun 2017
-
87.67%(-6.2%)
Mar 2017
-
93.49%(+4.6%)
Dec 2016
84.66%(+9.8%)
89.36%(+1.1%)
Sep 2016
-
88.38%(+3.0%)
Jun 2016
-
85.80%(-0.3%)
Mar 2016
-
86.07%(+1.1%)
Dec 2015
77.07%(+18.0%)
85.10%(+0.9%)
Sep 2015
-
84.34%(+2.6%)
Jun 2015
-
82.24%(0.0%)
Mar 2015
-
82.24%(+17.8%)
Dec 2014
65.34%(+9.9%)
69.81%(+1.3%)
Sep 2014
-
68.93%(-0.5%)
Jun 2014
-
69.29%(-0.4%)
Mar 2014
-
69.57%(+6.0%)
Dec 2013
59.47%(+10.3%)
65.64%(-2.7%)
Sep 2013
-
67.49%(-1.4%)
Jun 2013
-
68.45%(+5.2%)
Mar 2013
-
65.09%(+8.9%)
Dec 2012
53.92%(+10.7%)
59.76%(+1.8%)
Sep 2012
-
58.71%(+8.0%)
Jun 2012
-
54.35%(+8.3%)
Mar 2012
-
50.19%(+4.9%)
Dec 2011
48.69%(+27.9%)
47.85%(+3.4%)
Sep 2011
-
46.26%(+3.1%)
Jun 2011
-
44.89%(+3.1%)
Mar 2011
-
43.54%(+6.0%)
Dec 2010
38.08%(+23.6%)
41.06%(+12.1%)
Sep 2010
-
36.62%(+4.7%)
Jun 2010
-
34.98%(+2.9%)
Mar 2010
-
34.00%(+8.0%)
Dec 2009
30.82%(+1.2%)
31.48%(-0.2%)
Sep 2009
-
31.55%(+0.0%)
Jun 2009
-
31.54%(+2.0%)
Mar 2009
-
30.91%(+4.2%)
Dec 2008
30.45%(+12.8%)
29.67%(+13.7%)
Sep 2008
-
26.10%(+8.6%)
Jun 2008
-
24.03%(-13.1%)
Mar 2008
-
27.66%(+4.4%)
Dec 2007
26.99%(+20.5%)
26.50%(-11.1%)
Sep 2007
-
29.81%(+1.1%)
Jun 2007
-
29.49%(+22.3%)
Mar 2007
-
24.12%(+5.5%)
Dec 2006
22.39%(+5.7%)
22.87%(+6.1%)
Sep 2006
-
21.55%(-1.1%)
Jun 2006
-
21.80%(-1.1%)
Mar 2006
-
22.04%(-0.1%)
Dec 2005
21.18%(+14.6%)
22.06%(-7.3%)
Sep 2005
-
23.79%(+7.8%)
Jun 2005
-
22.07%(+7.8%)
Mar 2005
-
20.48%(+3.4%)
DateAnnualQuarterly
Dec 2004
18.48%(-6.4%)
19.80%(-2.6%)
Sep 2004
-
20.32%(-6.0%)
Jun 2004
-
21.62%(-10.6%)
Mar 2004
-
24.19%(-9.4%)
Dec 2003
19.75%(+6.5%)
26.69%(+26.7%)
Sep 2003
-
21.07%(+6.0%)
Jun 2003
-
19.87%(+16.5%)
Mar 2003
-
17.05%(-16.4%)
Dec 2002
18.55%(-13.0%)
20.39%(+2.6%)
Sep 2002
-
19.88%(+1.4%)
Jun 2002
-
19.61%(+1.2%)
Mar 2002
-
19.37%(-2.8%)
Dec 2001
21.31%(+11.7%)
19.93%(-7.7%)
Sep 2001
-
21.60%(-16.8%)
Jun 2001
-
25.97%(-3.3%)
Mar 2001
-
26.87%(+33.3%)
Dec 2000
19.07%(+34.1%)
20.16%(-19.4%)
Sep 2000
-
25.00%(+31.2%)
Jun 2000
-
19.05%(+7.3%)
Mar 2000
-
17.76%(+31.3%)
Dec 1999
14.22%(+8.2%)
13.53%(+9.0%)
Sep 1999
-
12.41%(-0.1%)
Jun 1999
-
12.42%(-4.7%)
Mar 1999
-
13.03%(-10.6%)
Dec 1998
13.14%(+4.7%)
14.58%(+2.2%)
Sep 1998
-
14.26%(+0.8%)
Jun 1998
-
14.14%(+6.6%)
Mar 1998
-
13.27%(-4.7%)
Dec 1997
12.55%(+6.8%)
13.93%(+20.1%)
Sep 1997
-
11.60%(+1.8%)
Jun 1997
-
11.39%(+1.8%)
Mar 1997
-
11.19%(-21.0%)
Dec 1996
11.75%(+0.2%)
14.16%(+25.2%)
Sep 1996
-
11.31%(+0.5%)
Jun 1996
-
11.25%(-1.0%)
Mar 1996
-
11.36%(-19.5%)
Dec 1995
11.73%(+2.0%)
14.11%(+3.1%)
Sep 1995
-
13.69%(+6.2%)
Jun 1995
-
12.89%(+16.1%)
Mar 1995
-
11.10%(-17.5%)
Dec 1994
11.50%(-10.1%)
13.46%(+14.1%)
Sep 1994
-
11.80%(+0.9%)
Jun 1994
-
11.70%(-2.0%)
Mar 1994
-
11.94%(-20.5%)
Dec 1993
12.79%(-0.3%)
15.02%(+15.3%)
Sep 1993
-
13.03%(+10.1%)
Jun 1993
-
11.84%(-3.1%)
Mar 1993
-
12.22%(-27.8%)
Dec 1992
12.83%(+24.2%)
16.92%(+53.1%)
Sep 1992
-
11.05%(0.0%)
Jun 1992
-
11.05%(+12.9%)
Mar 1992
-
9.79%(-27.4%)
Dec 1991
10.33%(-9.3%)
13.48%(+14.8%)
Sep 1991
-
11.74%(+6.4%)
Jun 1991
-
11.03%(+1.7%)
Mar 1991
-
10.85%(-22.8%)
Dec 1990
11.39%(-2.6%)
14.05%(+17.9%)
Sep 1990
-
11.92%(+4.7%)
Jun 1990
-
11.38%(+11.9%)
Mar 1990
-
10.17%(-26.5%)
Dec 1989
11.69%(+1.5%)
13.83%(+9.6%)
Sep 1989
-
12.62%(+7.0%)
Jun 1989
-
11.79%(-11.9%)
Mar 1989
-
13.38%(-10.1%)
Dec 1988
11.52%(+14.7%)
14.89%(+27.7%)
Sep 1988
-
11.66%(+2.9%)
Jun 1988
-
11.33%(+24.1%)
Mar 1988
-
9.13%(-25.5%)
Dec 1987
10.04%(-14.3%)
12.25%(+1.3%)
Sep 1987
-
12.09%(+0.5%)
Jun 1987
-
12.03%(-2.5%)
Mar 1987
-
12.34%(-5.0%)
Dec 1986
11.72%(-4.5%)
12.99%(+19.4%)
Sep 1986
-
10.88%(+3.6%)
Jun 1986
-
10.50%(+3.3%)
Mar 1986
-
10.16%(-2.4%)
Dec 1985
12.27%(-27.2%)
10.41%(-33.1%)
Sep 1985
-
15.55%(-3.8%)
Jun 1985
-
16.17%(-2.9%)
Mar 1985
-
16.66%(-1.2%)
Dec 1984
16.85%
16.87%

FAQ

  • What is Novo Nordisk A/S annual return on equity?
  • What is the all time high annual ROE for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual ROE year-on-year change?
  • What is Novo Nordisk A/S quarterly return on equity?
  • What is the all time high quarterly ROE for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly ROE year-on-year change?

What is Novo Nordisk A/S annual return on equity?

The current annual ROE of NVO is 81.76%

What is the all time high annual ROE for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual return on equity is 87.29%

What is Novo Nordisk A/S annual ROE year-on-year change?

Over the past year, NVO annual return on equity has changed by -5.53% (-6.34%)

What is Novo Nordisk A/S quarterly return on equity?

The current quarterly ROE of NVO is 86.85%

What is the all time high quarterly ROE for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly return on equity is 95.26%

What is Novo Nordisk A/S quarterly ROE year-on-year change?

Over the past year, NVO quarterly return on equity has changed by -2.94% (-3.27%)